secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001477449-24-000172
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q2 revenue down 2% to $642.4M; net loss $837.7M on $790M goodwill impairment; FY outlook withdrawn
--------------------------------------------------------------------------------

- Q2 revenue $642.4M (-2% YoY); net loss $837.7M ($4.92/sh) includes $790M goodwill impairment for BetterHelp.
- Adjusted EBITDA $89.5M (+24% YoY); Integrated Care +5% to $377.4M, BetterHelp -9% to $265.0M.
- Company withdraws FY2024 consolidated and BetterHelp outlook and three-year outlook; provides Integrated Care guidance only.
- New CEO Chuck Divita joined; comments on strengthening execution and streamlining organization.
- Cash from operations $88.7M; free cash flow $60.9M; capex $27.7M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000172/0001477449-24-000172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000172/tdoc-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001477449-24-000172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer